HRT Financial’s Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 FRXB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,122
Closed 3324
2023
Q3
$0 Buy
15,122
+121
+0.8% +$10 ﹤0.01% 3348
2023
Q2
$2K Buy
15,001
+1
+0% ﹤0.01% 2304
2023
Q1
$2K Buy
+15,000
New +$2.78K ﹤0.01% 2362

Other funds holding FRXB.WS

HRT Financial's FRXB.WS Position: Q4 2023 in Review

HRT Financial sold out of Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (FRXB.WS) in Q4 2023, closing a stake of 15,122 shares.

HRT Financial first reported a position in FRXB.WS in Q1 2023 and held it in 3 quarters. The position peaked at $2K in Q2 2023. 1 fund tracked by Wall St. Rank holds FRXB.WS as of Q4 2023.

  • HRT Financial reported no remaining Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 15,122 Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2023.
  • HRT Financial first reported a position in Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q1 2023 and held it in 3 quarters.
  • HRT Financial's Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $2K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.